Skip to main content
. Author manuscript; available in PMC: 2017 May 18.
Published in final edited form as: Drug Metab Pers Ther. 2017 Mar 1;32(1):23–32. doi: 10.1515/dmpt-2016-0039

Table 2.

Comparison of MTHFR677C > T genotypes and alleles between the study cohort and controls.

MTHFR677C > T Patients n = 89, % (95% CI) Controls n = 400, % (95% CI) Unadjusted-OR (95% CI) p-Value
Genotypes
 CC 72 (80.9; 71–88) 184 (46.0; 41–51) < 0.0001
 CT 8 (8.9; 4–17) 159 (39.8; 35–45)
 TT 9 (10.1; 5–18) 57 (14.2; 11–18)
 CC + CT : TT 80 (89.9; 81–95):9 (10.1; 5–18) 343 (85.8; 82–89):57 (14.2; 11–18) 0.68 (0.32–1.42) 0.39
 CC:CT + TT 72 (80.9; 71–88):17 (19.1; 12–29) 184 (46.0; 41–51):216 (54.0; 49–59) 0.20 (0.11–0.35) < 0.0001
Alleles
 C 152 (85.4; 79–90) 527 (65.9; 62–69) 0.33 (0.21–0.51) < 0.0001
 T 26 (14.6; 10–21) 273 (34.1; 31–37)

Two-sided 95% CI for the single proportion includes continuity correction.